Fibrinolytic Agents
Showing 1 - 25 of 5,467
Empyema, Pleural, Parapneumonic Effusion Trial in Seattle (drug, procedure, radiation, other, behavioral)
Completed
- Empyema, Pleural
- Parapneumonic Effusion
- Intrapleural Medications
- +7 more
-
Seattle, WashingtonSwedish Cancer Institute
Nov 17, 2022
Parapneumonic Effusion, Empyema, Pleural, Coagulopathy Trial in Denver (VATS Decortication, Fibrinolytic Therapy)
Completed
- Parapneumonic Effusion
- +2 more
- VATS Decortication
- Fibrinolytic Therapy
-
Denver, ColoradoDenver Health
Nov 19, 2021
Complicated Pleural Effusion/ Empyema Trial (Intrapleural Medications)
Unknown status
- Complicated Pleural Effusion/ Empyema
- Intrapleural Medications
- (no location specified)
Nov 5, 2018
Bladder Cancer Trial in Canada (Tranexamic Acid, Placebo)
Completed
- Bladder Cancer
- Tranexamic Acid
- Placebo
-
Edmonton, Alberta, Canada
- +9 more
Oct 3, 2022
Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder Trial in Australia (Intra-arterial tenecteplase injection at
Not yet recruiting
- Ischemic Stroke, Acute
- +3 more
- Intra-arterial tenecteplase injection at the completion of thrombectomy
- Placebo
-
Adelaide, Australia
- +11 more
May 26, 2023
Laboratory Indices to Left Ventricular Thrombus Formation in
Not yet recruiting
- Left Ventricular Thrombus
- Primary percutaneous coronary intervention or thrombolytic therapy
- (no location specified)
Nov 29, 2023
Acute Ischemic Stroke Trial in Houston (Thrombolytic Agent)
Recruiting
- Acute Ischemic Stroke
- Thrombolytic Agent
-
Houston, TexasMichael E. DeBakey VA Medical Center
Jun 8, 2022
Severe Acute Respiratory Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome Trial in United States (Alteplase 50
Completed
- Severe Acute Respiratory Syndrome
- +2 more
- Alteplase 50 MG [Activase]
-
La Jolla, California
- +8 more
Jan 18, 2022
Acute STROke Complicating TAVI - Management and Outcomes
Completed
- Stroke
- +2 more
- Mechanical thrombectomy
- Thrombolytic Agent
-
Petah tikva, IsraelRabin Medical Center
Feb 5, 2022
STEMI - ST Elevation Myocardial Infarction Trial in Shanghai (Thrombolytic, percutaneous coronary stenting)
Recruiting
- STEMI - ST Elevation Myocardial Infarction
- Thrombolytic
- percutaneous coronary stenting
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
May 20, 2022
MPV,PDW,PFT and ST Segment Resolution in STEMI Patients Treated
Withdrawn
- STEMI - ST Elevation Myocardial Infarction
- Thrombolytic
- +4 more
- (no location specified)
Feb 1, 2023
ST-segment Elevation Myocardial Infarction (STEMI) Trial in China (Recombinant Staphylokinase, Normal Saline)
Active, not recruiting
- ST-segment Elevation Myocardial Infarction (STEMI)
- Recombinant Staphylokinase
- Normal Saline
-
Nanjing, Jiangsu, China
- +7 more
Jan 30, 2023
Tissue Plasminogen Activator Trial in Columbia (early tPA and DNase)
Withdrawn
- Tissue Plasminogen Activator
- early tPA and DNase
-
Columbia, South CarolinaPalmetto Health Richland
Jan 31, 2022
Ischemic Stroke Trial in Worldwide (Direct endovascular clot retrieval, Bridging thrombolysis followed by ECR)
Completed
- Ischemic Stroke
- Direct endovascular clot retrieval
- Bridging thrombolysis followed by ECR
-
Liverpool, New South Wales, Australia
- +32 more
Jun 14, 2022
Stroke Research Consortium in Northern Bavaria (STAMINA)
Completed
- Ischemic Stroke
- thrombolysis therapy
- +5 more
-
Erlangen, Germany
- +1 more
Jul 29, 2022
Pulmonary Embolism Trial (mechanical fragmentation, In Situ thrombolysis)
Not yet recruiting
- Pulmonary Embolism
- mechanical fragmentation
- In Situ thrombolysis
- (no location specified)
Jun 14, 2021
Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal
Not yet recruiting
- Pleural Infection
- Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
- Saline irrigation with 250 mls normal saline (over 1 hour)
- (no location specified)
Jun 19, 2023
Von Willebrand Diseases, Postpartum Hemorrhage Trial in Pittsburgh (Recombinant Von Willebrand factor, Tranexamic Acid Injection
Recruiting
- Von Willebrand Diseases
- Postpartum Hemorrhage
- Recombinant Von Willebrand factor
- Tranexamic Acid Injection [Cyklokapron]
-
Pittsburgh, Pennsylvania
- +1 more
Jul 5, 2022
Pleural Empyema Trial (VATS group, Drain and intrapleural therapy group)
Recruiting
- Pleural Empyema
- VATS group
- Drain and intrapleural therapy group
-
Aarhus, Denmark
- +2 more
Jan 31, 2023
Ischemic Stroke, Thrombolytic (t-PA) Treatment, Gender Bias Trial in Barcelona (IV thrombolytic (t-PA) treatment vs not)
Completed
- Ischemic Stroke
- +3 more
- IV thrombolytic (t-PA) treatment vs not
-
Barcelona, SpainPlan Director Enfermedad Vascular Cerebral
Apr 3, 2022
An Investigator-initiated Linked Study to OCEANIC-AF
Recruiting
- Atrial Fibrillation
- Thrombotic assessment
-
Liverpool, United Kingdom
- +1 more
Nov 5, 2023
Platelet Membrane Cloaked Recombinant Staphylokinase on Human
Not yet recruiting
- Arterial Thrombosis
- collection of venous blood or arterial blood
- (no location specified)
Aug 6, 2023
Coronary Artery Disease Trial (Lansoprazole 15 mg)
Not yet recruiting
- Coronary Artery Disease
- Lansoprazole 15 mg
- (no location specified)
Apr 6, 2023
Management of TA in VaS-Patients and HT
Unknown status
- VTE After Stroke
- Antithrombotic Agents
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of the Air Force Medical Universit
Jan 25, 2021
Cerebral Hemorrhage, Intracranial Hemorrhages, Atrial Fibrillation Trial in Copenhagen, Oslo, Umeå (Antithrombotic Agent)
Recruiting
- Cerebral Hemorrhage
- +4 more
- Antithrombotic Agent
-
Copenhagen, Denmark
- +2 more
Sep 7, 2021